IP Library Granted Patent US 11,529,451
Granted Patent B2
US 11,529,451 · App. 14/396,690 · Granted Dec 20, 2022

Method and device for treating venous insufficiency and varicose veins

Inventor: Johann Christof Ragg (Berlin, DE)
Assignee: ANGIOCLINIC AG
A61M1/85A61B17/00491A61B17/12131A61B17/12186A61K9/122A61K31/08A61K47/02A61K47/32A61M25/007A61M25/01A61M2025/0006A61M2025/0175A61M2202/02A61M2210/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,529,451
App. No.
14/396,690
Granted
Dec 20, 2022
Kind
B2
Abstract

One larger [ 1 ] and one smaller tube [ 2 ], forming a functional unit with the smaller tube [ 2 ] positioned within the larger tube [ 1 ], both tubes are relocatable and demountable, both tubes with an aperture [ 3 and 4 ] at both ends, at least one aperture [ 5 ] being provided in the wall of the outer tube located at a distance of about between 1 mm and 10 cm from the tip [ 6 ], or several apertures positioned in a segment of 1-250 mm from the tip, wherein the diameter of the single aperture is between 70% and 120% of the inner diameter of the outer tube [ 1 ], or in case of several apertures, for each aperture 30-60% of the inner diameter of the outer tube, wherein the outer diameter of the inner tube is between 0.6 mm and 2.0 mm (F2 to F6), the outer diameter of the outer tube is between 1.3 mm and 3.6 mm (F4 to F11), and the distance between the outer wall of the inner tube and the inner wall of the outer tube is between 0.1 mm to 3.0 mm.

Claims (42)

1. A kit comprising:

a pharmaceutically acceptable tissue glue that can polymerize on contact with H 2 O, blood, or constituent parts of blood,

a medical gas, for use in treating varicose veins, and

a sclerosant drug,

wherein said medical gas is configured to be combined with said tissue glue to prepare a foam or gel glue for injection within a vein,

the kit further comprising a catheter having an outer tube and an inner tube, the outer tube being fluidly isolated from the inner tube and having at least one side hole provided therein,

wherein the outer tube of the catheter is designed to evacuate blood from a target vein, and to administer and withdraw the sclerosant drug through one or more holes of the at least one side hole, and the inner tube of the catheter is designed to administer a composition comprising the pharmaceutically acceptable tissue glue and the medical gas, wherein the inner tube of the catheter is configured to administer said tissue glue and said medical gas in a 1:1 to 1:4 ratio, and wherein the inner tube of the catheter is configured to administer said tissue glue in an amount of 0.1 mL to 0.5 mL per injection.

2. The kit according to claim 1 , wherein the outer tube contains the sclerosant drug, and wherein the inner tube contains the foam or gel glue.

3. The kit according to claim 2 , wherein the outer tube has opposing ends and a wall extending between the opposing ends, and wherein at least one aperture is defined within the wall of the outer tube.

4. A method of treating a subject using a kit having a composition and a double tube injection and aspiration catheter, the method comprising:

intravenously applying, at one or more sites of treatment, the composition by the double tube injection and aspiration catheter, the catheter having an outer tube and an inner tube, the outer tube having at least one side hole provided therein, the composition comprising:

a) a pharmaceutically acceptable tissue glue that can polymerize on contact with H 2 O, blood or constituent parts of blood,

b) a medical gas, for use in treating varicose veins, and

c) a sclerosant drug; and

performing the following steps at each of the one or more sites of treatment:

aspirating blood of the subject through one or more holes of the at least one side hole provided in the outer tube to collapse a vein;

administering the sclerosant drug as a first foam through one or more holes of the at least one side hole provided in the outer tube;

aspirating the sclerosant drug through one or more holes of the at least one side hole provided in the outer tube; and

applying the tissue glue and medical gas via the inner tube as a second foam or gel while maintaining negative pressure via the outer tube,

wherein said medical gas is combined with said tissue glue to prepare the second foam or gel for injection within the vein,

wherein said tissue glue and said medical gas are applied in a 1:1 to 1:4 ratio, and

wherein said tissue glue is provided in an amount of 0.1 mL to 0.5 mL per injection.

5. The method according to claim 4 , wherein the tissue glue is selected from the list of cyanoacrylate and fibrin glue.

6. The method according to claim 4 , wherein the medical gas is selected from the list of carbon dioxide, oxygen, air, or mixtures thereof.

7. The method according to claim 4 , wherein said tissue glue and said medical gas are loaded in the inner tube of the double tube injection and aspiration catheter.

8. The method according to claim 4 , wherein said tissue glue and said medical gas are loaded in the inner tube of the double tube injection and aspiration catheter.

9. A method of treating a subject using a kit having a composition and a double tube injection and aspiration catheter, the method comprising:

intravenously applying, at one or more sites of treatment, the composition by the double tube injection and aspiration catheter, the catheter having an outer tube and an inner tube, the outer tube having at least one side hole provided therein, the composition comprising:

a) a pharmaceutically acceptable tissue glue that can polymerize on contact with H 2 O, blood or constituent parts of blood,

b) a medical gas, for use in treating varicose veins, and

c) a sclerosant drug; and

performing the following steps at each of the one or more sites of treatment:

aspirating blood of the subject through one or more holes of the at least one side hole of the outer tube to collapse a vein;

administering the sclerosant drug as a first foam through one or more holes of the at least one side hole of the outer tube;

aspirating the sclerosant drug through one or more holes of the at least one side hole of the outer tube; and

sequentially applying the medical gas and the tissue glue via the inner tube while maintaining negative pressure via the outer tube,

wherein at least a first portion of the medical gas is applied in a first bolus and the tissue glue is subsequently applied in a second bolus, and

wherein said tissue glue and said medical gas are applied in a 1:1 to 1:4 ratio, and

wherein said tissue glue is provided in an amount of 0.1 mL to 0.5 mL per injection.

10. The method according to claim 9 , wherein a second portion of the medical gas is applied in a third bolus following application of the second bolus.

11. The method according to claim 9 , wherein the tissue glue is selected from the list of cyanoacrylate and fibrin glue.

12. The method according to claim 9 , wherein the medical gas is selected from the list of carbon dioxide, oxygen, air, or mixtures thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2015
From: RAGG, JOHANN CHRISTOF
To: ANGIOCLINIC AG
Reel/Frame 034894/0440 →
Priority Claims (1)
EP 12165246 · Apr 24, 2012 · regional
Continuity (1)
Related Publication 20150088051A1 · Mar 26, 2015